Note 1 - Organization and Nature of Operations |
6 Months Ended |
|---|---|
Jun. 30, 2025 | |
| Notes to Financial Statements | |
| Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] |
1. ORGANIZATION AND NATURE OF OPERATIONS
Reviva Pharmaceuticals Holdings, Inc. (together with its consolidated subsidiaries, the “Company”) is a late-stage pharmaceutical company developing new therapies that seek to address unmet medical needs in the areas of central nervous system ("CNS"), inflammatory and cardiometabolic diseases.
Reviva Pharmaceuticals, Inc. was originally incorporated in the state of Delaware and commenced operations on May 1, 2006 and its Indian subsidiary, Reviva Pharmaceuticals India Pvt. Ltd. was incorporated in 2014.
On December 14, 2020, the Company completed a business combination pursuant to which Tenzing Merger Subsidiary Inc., a wholly-owned subsidiary of Tenzing Acquisition Corp., merged with and into Reviva Pharmaceuticals, Inc., with Reviva Pharmaceuticals, Inc. surviving the merger. As a result, Reviva Pharmaceuticals, Inc. became a wholly-owned subsidiary of the Company. In these notes to the unaudited condensed consolidated financial statements, unless otherwise specified or the context indicates otherwise, references to the “Company,” “Reviva,” “we,” “us” and “our” refer to Reviva Pharmaceuticals Holdings, Inc. and its consolidated subsidiaries. |